P. Alonso

Metastatic Colon Cancer: Is Rechallenging Still An Option Beyond Second Line? A Quick Review.

E. U. Cidon, Miriam López, P. Alonso, 2020 .

Pilot Study Of Insomnia Prevalence In Cancer Survivors

E. U. Cidon, P. Alonso, 2013 .

Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?

E. U. Cidon, P. Alonso, B. Masters, 2016, Clinical Medicine Insights. Oncology.

Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen

P. Alonso, G. Manga, H. Carbuccia, 2004, Cancer Chemotherapy and Pharmacology.

The role of cardiac biomarkers in early detection of cardiotoxicity in breast cancer treated with trastuzumab in the adjuvant setting: a systematic review

T. Hickish, E. U. Cidon, P. Alonso, 2021 .

Widespread use of pemetrexed in oncology: has it turned it into a new drug?

E. U. Cidon, T. Geldart, P. Alonso, 2014, Chinese clinical oncology.

P-124Gemcitabine-induced pseudocellulitis in patients with pancreatic adenocarcinoma or cholangiocarcinoma

E. U. Cidon, P. Alonso, 2016 .